Akorn, Inc. (NASDAQ: AKRX) has entered into an agreement to acquire from Eli Lilly and Company (NYSE: LLY) all rights ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE